Mahmood Abedinzade
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Mahmood Abedinzade has a total of 111 co-authors. Here are the top co-authors by number of shared publications:
Korosh Khanaki
6 shared publications- Korosh Khanaki
Medical Biotechnology Research Center, School of Paramedicine, Guilan University of Medical Sciences, Rasht, Iran
5 shared publications Ahmad Ghorbani
Pharmacological Research Center of Medicinal Plants, Mashhad University of Medical Sciences, Mashhad, Iran
3 shared publications- Zahra Bostani Khalesi
Biomedicine Research Center, Trauma Institute, Guilan University of Medical Sciences, Rasht, Iran
3 shared publications Ekram Mohammadi
Iran University of Medical Sciences, Tehran, Islamic Republic of Iran
2 shared publicationsFakhroddin Aghajanpour
Department of Reproductive Biology and Anatomical Sciences, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2 shared publications
Latest Publications
- Open Access
- 26 May 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Quercetin-loaded cellulose nanofibers improve memory, learning, and attenuate endoplasmic reticulum stress in a rat model of Alzheimer’s disease
Alzheimer's disease (AD) lacks effective disease-modifying therapy. This study evaluated the neuroprotective efficacy of quercetin-loaded cellulose nanofibers (QNP) in a streptozotocin (STZ)-induced AD rat model, focusing on memory impairment and endoplasmic reticulum (ER) stress. Forty-eight male Wistar rats were randomly allocated to six groups (n = 8): Control, AD model (ICV STZ 3 mg/kg on days 1 and 3), STZ + empty cellulose nanoparticles, STZ + free quercetin (10 mg/kg IP), STZ + QNP (10 mg/kg IP, equivalent quercetin dose), and STZ + donepezil (1 mg/kg IP) for 14 days. Morris water maze testing revealed that QNP significantly reduced escape latency during acquisition (31%, P < 0.001 vs. AD model) and increased time spent in the target quadrant during the probe trial (P < 0.01). QNP treatment resulted in significantly greater improvement compared to an equivalent dose of free quercetin (P < 0.05). RT-PCR demonstrated XBP-1 mRNA splicing exclusively in the AD model group, indicating activation of the unfolded protein response (UPR). Both free quercetin and QNP completely prevented this splicing, demonstrating potent suppression of ER stress. Cellulose nanofiber-mediated delivery significantly enhances quercetin's bioavailability and therapeutic efficacy, ameliorating cognitive deficits in AD likely via mitigation of ER stress. QNP represents a promising, biocompatible nano-therapeutic strategy for Alzheimer's disease.
- 26 May 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessQuercetin-loaded cellulose nanofibers improve memory, learning, and attenuate endoplasmic reticulum stress in a rat model of Alzheimer’s disease
Alzheimer's disease (AD) lacks effective disease-modifying therapy. This study evaluated the neuroprotective efficacy of quercetin-loaded cellulose nanofibers (QNP) in a streptozotocin (STZ)-induced AD rat model, focusing on memory impairment and endoplasmic reticulum (ER) stress. Forty-eight male Wistar rats were randomly allocated to six groups (n = 8): Control, AD model (ICV STZ 3 mg/kg on days 1 and 3), STZ + empty cellulose nanoparticles, STZ + free quercetin (10 mg/kg IP), STZ + QNP (10 mg/kg IP, equivalent quercetin dose), and STZ + donepezil (1 mg/kg IP) for 14 days. Morris water maze testing revealed that QNP significantly reduced escape latency during acquisition (31%, P < 0.001 vs. AD model) and increased time spent in the target quadrant during the probe trial (P < 0.01). QNP treatment resulted in significantly greater improvement compared to an equivalent dose of free quercetin (P < 0.05). RT-PCR demonstrated XBP-1 mRNA splicing exclusively in the AD model group, indicating activation of the unfolded protein response (UPR). Both free quercetin and QNP completely prevented this splicing, demonstrating potent suppression of ER stress. Cellulose nanofiber-mediated delivery significantly enhances quercetin's bioavailability and therapeutic efficacy, ameliorating cognitive deficits in AD likely via mitigation of ER stress. QNP represents a promising, biocompatible nano-therapeutic strategy for Alzheimer's disease.
- Open Access
- 1 December 2025
- Published by Taylor & Francis in International Journal of Women's Health
- Vol. ume 17, 5425-5438
Innovative Drug Delivery Systems for Management of Menopausal Symptoms: A Systematic Review
Menopause characterized by estrogen deficiency and has various symptoms, including vasomotor, genitourinary, and psychological manifestations. Innovative drug delivery systems (IDDSs) offer targeted approaches that increase therapeutic efficacy, reduce side effects, and improve patient adherence. To update our knowledge about Drug Delivery Systems (DDS) for decrease menopausal symptoms and its benefits compare with conventional systems. This review systematically examines the application and clinical potential of IDDS for managing menopause-related symptoms, with a particular emphasis on improvements in efficacy, safety, and patient adherence. A comprehensive literature search across multiple databases (PubMed, Em-base, Cochran, Scopus; 2001– 2024) yielded 23 studies, including RCTs and observational studies on trans dermal, intravaginal, and Nano-based DDS s (patches, vaginal rings, nano particles) and Neurokinin-3 (NK3) antagonists. Transdermal systems, such as estrogen patches, maintained stable hormone levels and reduced thromboembolism risk by 30% compared to oral hormone replacement therapy (HRT), by bypassing first-pass metabolism. Intravaginal DDS s, like estradiol rings, relieved genitourinary symptoms with less than 1% systemic absorption, thereby minimizing endometrial risks. Non-hormonal Neurokini3 antagonists like fezolinetant, decreased VMS by 60% and benefited high-risk patients. Emerging technologies, like hydro gels, showed preclinical potential but lack long-term safety data. Adherence to treatment was better with sustained-release formulations, such as pellet implants, compared to daily dosing regimens. DDSs offer personalized menopause management, balancing safety and efficacy. Future research should focus on pharmacogenomics, equity, and long-term safety of advanced DDSs, especially those using nanotechnology.
- 1 December 2025
- Published by Taylor & Francis in International Journal of Women's Health
- Vol. ume 17, 5425-5438
Open AccessInnovative Drug Delivery Systems for Management of Menopausal Symptoms: A Systematic Review
Menopause characterized by estrogen deficiency and has various symptoms, including vasomotor, genitourinary, and psychological manifestations. Innovative drug delivery systems (IDDSs) offer targeted approaches that increase therapeutic efficacy, reduce side effects, and improve patient adherence. To update our knowledge about Drug Delivery Systems (DDS) for decrease menopausal symptoms and its benefits compare with conventional systems. This review systematically examines the application and clinical potential of IDDS for managing menopause-related symptoms, with a particular emphasis on improvements in efficacy, safety, and patient adherence. A comprehensive literature search across multiple databases (PubMed, Em-base, Cochran, Scopus; 2001– 2024) yielded 23 studies, including RCTs and observational studies on trans dermal, intravaginal, and Nano-based DDS s (patches, vaginal rings, nano particles) and Neurokinin-3 (NK3) antagonists. Transdermal systems, such as estrogen patches, maintained stable hormone levels and reduced thromboembolism risk by 30% compared to oral hormone replacement therapy (HRT), by bypassing first-pass metabolism. Intravaginal DDS s, like estradiol rings, relieved genitourinary symptoms with less than 1% systemic absorption, thereby minimizing endometrial risks. Non-hormonal Neurokini3 antagonists like fezolinetant, decreased VMS by 60% and benefited high-risk patients. Emerging technologies, like hydro gels, showed preclinical potential but lack long-term safety data. Adherence to treatment was better with sustained-release formulations, such as pellet implants, compared to daily dosing regimens. DDSs offer personalized menopause management, balancing safety and efficacy. Future research should focus on pharmacogenomics, equity, and long-term safety of advanced DDSs, especially those using nanotechnology.
- Open Access
- 22 January 2024
- Published by SCI AND TECH UNIVERSAL INC in Journal of Obstetrics, Gynecology and Cancer Research
- Vol. 9 (1) , 29-35
Preventive Dose of Melatonin on Postoperative Pain in Total Abdominal Hysterectomy: A Clinical Trial Study
Background & Objective: Studies have shown contradictory results regarding the use of pregabalin and melatonin as analgesic agents. Because the analgesic effects of these drugs as preemptive have not been compared in abdominal hysterectomy, one of the most common surgical procedures in women with moderate to severe pain, under general anesthesia. The aim of this study was to compare the pretreatment effects of melatonin and pregabalin on postoperative pain intensity in total abdominal hysterectomy (TAH).Materials & Methods: Ninety Patients were randomly divided into three groups (N=30): the first group received oral melatonin (6 mg), the second group received pregabalin (50 mg), and the third one who took no drug. Serum melatonin and beta-endorphin levels were measured before and after the surgery. Pain intensity was assessed by the Numerical Rating Scale at 1,6,12, and 24 hours after the surgeries.Results: At 12 hrs after the surgery, mean pain intensity in the melatonin group was significantly lower than the pregabalin group, and in the pregabalin group was significantly lower than the third group (P<0.05). At 24 hrs after the TAH, the mean pain intensity in the melatonin group was significantly lower than the third group (P<0.05).Conclusion: Injection preventive melatonin is more effective than pregabalin to reduce pain throughout the first 24 hrs after the TAH.
- 22 January 2024
- Published by SCI AND TECH UNIVERSAL INC in Journal of Obstetrics, Gynecology and Cancer Research
- Vol. 9 (1) , 29-35
Open AccessPreventive Dose of Melatonin on Postoperative Pain in Total Abdominal Hysterectomy: A Clinical Trial Study
Background & Objective: Studies have shown contradictory results regarding the use of pregabalin and melatonin as analgesic agents. Because the analgesic effects of these drugs as preemptive have not been compared in abdominal hysterectomy, one of the most common surgical procedures in women with moderate to severe pain, under general anesthesia. The aim of this study was to compare the pretreatment effects of melatonin and pregabalin on postoperative pain intensity in total abdominal hysterectomy (TAH).Materials & Methods: Ninety Patients were randomly divided into three groups (N=30): the first group received oral melatonin (6 mg), the second group received pregabalin (50 mg), and the third one who took no drug. Serum melatonin and beta-endorphin levels were measured before and after the surgery. Pain intensity was assessed by the Numerical Rating Scale at 1,6,12, and 24 hours after the surgeries.Results: At 12 hrs after the surgery, mean pain intensity in the melatonin group was significantly lower than the pregabalin group, and in the pregabalin group was significantly lower than the third group (P<0.05). At 24 hrs after the TAH, the mean pain intensity in the melatonin group was significantly lower than the third group (P<0.05).Conclusion: Injection preventive melatonin is more effective than pregabalin to reduce pain throughout the first 24 hrs after the TAH.
- 3 September 2023
- Published by Taylor & Francis in Experimental Aging Research
- Vol. 50 (5) , 633-651
Therapeutic Effects Of Combined and Chronic Treatment of Tat-GluA23y and D-Serine on Cognitive Dysfunction in Postmenopausal Rats
Background: The incidence of Alzheimer's disease (AD) in female gender compared with male has been addressed as a health concern, particularly in menopausal age. We here hypothesized that co-administration of NMDARs agonist (D-serine) and AMPARs endocytosis inhibitor (Tat-GluA23y) might be a potential target for alleviating memory impairment in sporadic Alzheimer model of rats.Methods: Forty-eight female Wistar rats weighing 200-220 randomly divided into six groups. One month later, ovariectomized rats underwent stereotaxic surgery and were cannulated into the brain lateral ventricles. Streptozotocin was injected (3 mg/kg), then animals received the related treatments until the day 51, which experienced acquisition of spatial memory in Morris Water Maze test. Finally, the level of phosphorylated cAMP response element binding protein (CREB) in the hippocampus was measured by Western blotting.Results: Co-administration of D-serine and GluA23y significantly enhanced the acquisition and retrieval of impaired spatial memory in ovariectomized rats with AD (p < .001). Compared to Glu-A 23, D-serine caused more improvement in the mentioned parameters above, however, these values for both groups were still significantly different from the control group (P < .05).Conclusion: Simultaneous treatment with D-serine and GluA23y synergistically improved STZ induced spatial memory impairment in OVX rat, probably partly via increase in phosphorylated CREB protein.
- 3 September 2023
- Published by Taylor & Francis in Experimental Aging Research
- Vol. 50 (5) , 633-651
Therapeutic Effects Of Combined and Chronic Treatment of Tat-GluA23y and D-Serine on Cognitive Dysfunction in Postmenopausal Rats
Background: The incidence of Alzheimer's disease (AD) in female gender compared with male has been addressed as a health concern, particularly in menopausal age. We here hypothesized that co-administration of NMDARs agonist (D-serine) and AMPARs endocytosis inhibitor (Tat-GluA23y) might be a potential target for alleviating memory impairment in sporadic Alzheimer model of rats.Methods: Forty-eight female Wistar rats weighing 200-220 randomly divided into six groups. One month later, ovariectomized rats underwent stereotaxic surgery and were cannulated into the brain lateral ventricles. Streptozotocin was injected (3 mg/kg), then animals received the related treatments until the day 51, which experienced acquisition of spatial memory in Morris Water Maze test. Finally, the level of phosphorylated cAMP response element binding protein (CREB) in the hippocampus was measured by Western blotting.Results: Co-administration of D-serine and GluA23y significantly enhanced the acquisition and retrieval of impaired spatial memory in ovariectomized rats with AD (p < .001). Compared to Glu-A 23, D-serine caused more improvement in the mentioned parameters above, however, these values for both groups were still significantly different from the control group (P < .05).Conclusion: Simultaneous treatment with D-serine and GluA23y synergistically improved STZ induced spatial memory impairment in OVX rat, probably partly via increase in phosphorylated CREB protein.
- 10 October 2022
- Published by Elsevier in Gene Reports
- Vol. 29
Effects of Urtica dioica extract on caspase-3 and cyclooxygenase-2 genes expression in a rat stroke model
- 10 October 2022
- Published by Elsevier in Gene Reports
- Vol. 29
Effects of Urtica dioica extract on caspase-3 and cyclooxygenase-2 genes expression in a rat stroke model
- Open Access
- 30 June 2022
- Published by CMV Verlag in Journal of Current Biomedical Reports
- Vol. 3 (2) , 84-90
The effect of N2O gas on serum cobalamin and homocysteine in patients undergoing orthopedic surgery
Nitrous oxide (N2O) is an inhaled anesthetic drug that uses during surgery and recently proposed as a treatment for mood disorder in a research setting. Exposure to N2O during surgery can cause hematopoietic and neural side effects. The purpose of this study was to the designation of serum cobalamin, homocysteine and CBC factors changes after exposure to nitrous oxide during orthopedic surgery. This study has been done on 30 patients undergoing orthopedic operations from 2016 until 2018. All patients are scheduled for orthopedic surgery. All patients received nitrous oxide during their anesthesia period. Blood samples were taken from patients 48 hours before surgery and 24 hours after surgery. All samples froze at -20°c immediately after collecting. Then samples transferred to the university laboratory with regards to keeping a cold chain for analysis. Paired T-test and Wilcoxon test were used for comparing vitamin B12, homocysteine, and CBC parameters. Nitrous oxide resulted in marked vitamin B12 and homocysteine level change. Mean concentration of vitamin B12 reduced after exposure to N2O. This difference was significant when analyzed using paired sample T-test (p=0.0001). homocysteine concentration means decreased after exposure to N2O and this difference was statistically significant (p=0.0001). Nitrous oxide will lead to a decrease in vitamin B12 and an increase in homocysteine and mean corpuscular volume in the early postoperative period.
- 30 June 2022
- Published by CMV Verlag in Journal of Current Biomedical Reports
- Vol. 3 (2) , 84-90
Open AccessThe effect of N2O gas on serum cobalamin and homocysteine in patients undergoing orthopedic surgery
Nitrous oxide (N2O) is an inhaled anesthetic drug that uses during surgery and recently proposed as a treatment for mood disorder in a research setting. Exposure to N2O during surgery can cause hematopoietic and neural side effects. The purpose of this study was to the designation of serum cobalamin, homocysteine and CBC factors changes after exposure to nitrous oxide during orthopedic surgery. This study has been done on 30 patients undergoing orthopedic operations from 2016 until 2018. All patients are scheduled for orthopedic surgery. All patients received nitrous oxide during their anesthesia period. Blood samples were taken from patients 48 hours before surgery and 24 hours after surgery. All samples froze at -20°c immediately after collecting. Then samples transferred to the university laboratory with regards to keeping a cold chain for analysis. Paired T-test and Wilcoxon test were used for comparing vitamin B12, homocysteine, and CBC parameters. Nitrous oxide resulted in marked vitamin B12 and homocysteine level change. Mean concentration of vitamin B12 reduced after exposure to N2O. This difference was significant when analyzed using paired sample T-test (p=0.0001). homocysteine concentration means decreased after exposure to N2O and this difference was statistically significant (p=0.0001). Nitrous oxide will lead to a decrease in vitamin B12 and an increase in homocysteine and mean corpuscular volume in the early postoperative period.
- Open Access
- 30 April 2022
- Published by Pensoft Publishers in Folia Medica
- Vol. 64 (2) , 275-282
Potential anti-inflammatory effect of Lamium album extract through caspase-3 and cyclooxygenase-2 genes expression in a rat model of middle cerebral artery occlusion
Introduction: Stroke is one of the most common causes of death worldwide. Inflammation and apoptosis play an important role in the cascade of ischemic stroke. Aim: The aim of the present study was to evaluate the pretreatment effects of Lamium album (L. album) extract on caspase-3 and cyclooxygenase-2 (COX-2) expression, infarct volume, and neurological deficit score in a rat model of middle cerebral artery occlusion (MCAO). Materials and methods: Wistar male rats were randomly divided into three groups: 1) MCAO group (1 h after MCAO, reperfusion was allowed for 24 h by retracting the thread); 2) L. album + MCAO group [receiving L. album extract (100 mg/kg via intraperitoneal) for a week before MCAO]; 3) sham group. The expression level of caspase-3 and COX-2 in the core, penumbra, and subcortex regions was measured by real time-PCR technique. Infarct volume and neurological deficit score were also assessed. Results: The mRNA expression of caspase-3 in the core, penumbra, and subcortex regions in L. album group was significantly reduced compared to MCAO group (pL. album was statistically decreased relative to MCAO group (pL. album group compared with MCAO group (pppL. album group in comparison with the MCAO group (pConclusions: It appears that pretreatment with L. album extract may attenuate brain tissue damage after ischemic stroke. The potential protective effects of this plant extract against this condition might be in part attributed to its anti-inflammatory and anti-apoptotic activities.
- 30 April 2022
- Published by Pensoft Publishers in Folia Medica
- Vol. 64 (2) , 275-282
Open AccessPotential anti-inflammatory effect of Lamium album extract through caspase-3 and cyclooxygenase-2 genes expression in a rat model of middle cerebral artery occlusion
Introduction: Stroke is one of the most common causes of death worldwide. Inflammation and apoptosis play an important role in the cascade of ischemic stroke. Aim: The aim of the present study was to evaluate the pretreatment effects of Lamium album (L. album) extract on caspase-3 and cyclooxygenase-2 (COX-2) expression, infarct volume, and neurological deficit score in a rat model of middle cerebral artery occlusion (MCAO). Materials and methods: Wistar male rats were randomly divided into three groups: 1) MCAO group (1 h after MCAO, reperfusion was allowed for 24 h by retracting the thread); 2) L. album + MCAO group [receiving L. album extract (100 mg/kg via intraperitoneal) for a week before MCAO]; 3) sham group. The expression level of caspase-3 and COX-2 in the core, penumbra, and subcortex regions was measured by real time-PCR technique. Infarct volume and neurological deficit score were also assessed. Results: The mRNA expression of caspase-3 in the core, penumbra, and subcortex regions in L. album group was significantly reduced compared to MCAO group (pL. album was statistically decreased relative to MCAO group (pL. album group compared with MCAO group (pppL. album group in comparison with the MCAO group (pConclusions: It appears that pretreatment with L. album extract may attenuate brain tissue damage after ischemic stroke. The potential protective effects of this plant extract against this condition might be in part attributed to its anti-inflammatory and anti-apoptotic activities.
- Open Access
- 1 April 2022
- Published by Negah Scientific Publisher in Journal of Guilan University of Medical Sciences
- Vol. 31 (01) , 50-61
Effect of Synbiotics on Lipid Profile and Serum Levels of Gonadotropins, Insulin and Glucose in Rats with Polycystic Ovary Syndrome Induced by Lipopolysaccharide
Background: In women of childbearing age, Polycystic Ovary Syndrome (PCOS) is a common endocrine disorder. The cause of PCOS is still unknown and several factors may be involved. Objective: This study aims to evaluate the effect of synbiotics on serum parameters such as Follicle-Stimulating Hormone (FSH), Luteinizing Hormone (LH), triglyceride, cholesterol, glucose, ...
- 1 April 2022
- Published by Negah Scientific Publisher in Journal of Guilan University of Medical Sciences
- Vol. 31 (01) , 50-61
Open AccessEffect of Synbiotics on Lipid Profile and Serum Levels of Gonadotropins, Insulin and Glucose in Rats with Polycystic Ovary Syndrome Induced by Lipopolysaccharide
Background: In women of childbearing age, Polycystic Ovary Syndrome (PCOS) is a common endocrine disorder. The cause of PCOS is still unknown and several factors may be involved. Objective: This study aims to evaluate the effect of synbiotics on serum parameters such as Follicle-Stimulating Hormone (FSH), Luteinizing Hormone (LH), triglyceride, cholesterol, glucose, ...
- 1 January 2022
- Published by Negah Scientific Publisher in Basic and Clinical Neuroscience Journal
- Vol. 13 (1) , 71-80
Protective Effect of the Viola spathulata Extract on NCX3 Gene Expression in an Animal Model of Cerebral Ischemia
Introduction: Viola plant has been used traditionally to treat neurological disorders. We aimed at determining whether pretreatment with Viola spathulata extract can alleviate the severity of ischemic-reperfusion damages and exert its protective effects through the regulation of a sodium/calcium exchanger (NCX3) gene expression in a rat brain. Methods: Male Wistar rats were divided into two main groups: one main group for evaluating Neurologic Deficit Score (NDS) and Infarct Volume (IV) and the other group for the evaluation of NCX3 gene expression in the brain tissue. The latter group was subdivided into the intact, control (vehicle), sham, V5, and V10. The vehicle (control) subgroup received Dimethyl Sulfoxide (DMSO), and V5 and V10 subgroups received V. spathulata extract at the doses of 5 and 10 mg/kg (IP), respectively, for 7 days. After pretreatment, we carried out Middle Cerebral Artery Occlusion (MCAO) for 60 min. Results: In the V5 and V10 subgroups, NDS and IV significantly decreased. MCAO upregulated NCX3 gene expression in the core, penumbra, and subcortical regions compared with the intact subgroup. The V5 subgroup significantly downregulated the NCX3 gene expression level in the core compared with the control subgroup. The V10 subgroup showed downregulation of the NCX3 gene expression level in the core, penumbra, and subcortex compared with the control subgroup. Conclusion: V. spathulata extract may have a neuroprotective role against MCAO-induced ischemic brain damage, possibly by preventing the alteration of NCX3 gene expression level.
- 1 January 2022
- Published by Negah Scientific Publisher in Basic and Clinical Neuroscience Journal
- Vol. 13 (1) , 71-80
Protective Effect of the Viola spathulata Extract on NCX3 Gene Expression in an Animal Model of Cerebral Ischemia
Introduction: Viola plant has been used traditionally to treat neurological disorders. We aimed at determining whether pretreatment with Viola spathulata extract can alleviate the severity of ischemic-reperfusion damages and exert its protective effects through the regulation of a sodium/calcium exchanger (NCX3) gene expression in a rat brain. Methods: Male Wistar rats were divided into two main groups: one main group for evaluating Neurologic Deficit Score (NDS) and Infarct Volume (IV) and the other group for the evaluation of NCX3 gene expression in the brain tissue. The latter group was subdivided into the intact, control (vehicle), sham, V5, and V10. The vehicle (control) subgroup received Dimethyl Sulfoxide (DMSO), and V5 and V10 subgroups received V. spathulata extract at the doses of 5 and 10 mg/kg (IP), respectively, for 7 days. After pretreatment, we carried out Middle Cerebral Artery Occlusion (MCAO) for 60 min. Results: In the V5 and V10 subgroups, NDS and IV significantly decreased. MCAO upregulated NCX3 gene expression in the core, penumbra, and subcortical regions compared with the intact subgroup. The V5 subgroup significantly downregulated the NCX3 gene expression level in the core compared with the control subgroup. The V10 subgroup showed downregulation of the NCX3 gene expression level in the core, penumbra, and subcortex compared with the control subgroup. Conclusion: V. spathulata extract may have a neuroprotective role against MCAO-induced ischemic brain damage, possibly by preventing the alteration of NCX3 gene expression level.
- 27 December 2021
- Published by Doc Design and Informatics Co. Ltd. in Klimik Dergisi/Klimik Journal
- Vol. 34 (3) , 203-210
Molecular Pathogenicity of Wild-Endotoxin Derived from Burned Patient’s Skin and Proposed Effectiveness of Calcium Channel Inhibitors
Amaç: Sistemik bakteriyel endotoksin maruziyeti hepatik dokularda LUCOGS (“lipopolysaccharide (LPS)-unfolded protein response (UPR)- calcium overload-gene splicing”) açısından risk oluşturmaktadır. LUCOGS mekanizması ve sepsisle ilişkili süreci başlatmak üzere birbirleriyle etkileşimi tam olarak açığa kavuşmamıştır. Bu in vivo çalışma, hepatik uçbirleştirme ve UPR arasındaki ilişkinin aydınlatılmasını amaçlamaktadır. Yöntemler: Aydınlatılmış onam sonrasında hastaların yanık yaralarından Pseudomonas aeruginosa izolasyonu gerçekleştirilmiş ve LPS elde edilmiştir (hLPS). Erkek c57/BL6 fareler 6 gruba ayrılmıştır: 1. negatif kontrol (steril, apirojen normal salin) 2. pozitif kontrol (Tunikamisin) , 3. hLPS (3 mg/kg/intraperitoneal), 4. hLPS+ Dantrolen sodyum (kalsiyum kanal blokeri, CCI1) (A), 5. hLPS+2-aminometil fenil borinat (1 mg/kg) (CCI2) (B) ve 6. hLPS+CCI1/CCI2 (C). Uygulamalardan 2, 8 ve 24 saat sonra farelerin karaciğerleri adaptif UPR aktivasyonunun göstergesi olan XBP-1 birleştirmesinin değerlendirilmesi için çıkarılmıştır. Bulgular: hLPS grubuna kıyasla kombine hLPS ve CCl gruplarında XBP-1 birleştirme sayısı anlamlı olarak artış göstermiştir. Kontrollere kıyasla en yüksek XBP-1 birleştirme sayısı, Grup C’de 8 ve 24 saat sonra görülmüştür. Sonuçlar: Elde ettiğimiz veriler, CCl ile kombinasyonun, UPR gen uçbirleştirmesi modifikasyonu aracılığıyla hLPS ile indüklenmiş proinflamatuar aktivasyonu engelleyebileceğini göstermektedir. İki tür CCl uygulaması yaklaşımı ile indüklenmiş endotoksemi sonrasında hücre içi kalsiyum aşırı yüklenmesinin engellenmesi mümkün olabilir. Ayrı ayrı uygulanmalarına kıyasla kalsiyum kanal blokerlerinin birlikte uygulanmaları, (pro) inflamatuar süreçleri inhibe etme etkinliğini artırdığından sistemik dolaşımda LUGOGS yükselmesinin durdurulması ve organ yetmezliğinin engellenmesi için yeni bir strateji olarak değerlendirilebilir. Öne sürülen bu etkileşim mekanizmasının in vivo olarak daha detaylı ortaya konması için yeni uygulamanın etkinliğinin başka çalışmalarla desteklenmesi gereklidir.
- 27 December 2021
- Published by Doc Design and Informatics Co. Ltd. in Klimik Dergisi/Klimik Journal
- Vol. 34 (3) , 203-210
Molecular Pathogenicity of Wild-Endotoxin Derived from Burned Patient’s Skin and Proposed Effectiveness of Calcium Channel Inhibitors
Amaç: Sistemik bakteriyel endotoksin maruziyeti hepatik dokularda LUCOGS (“lipopolysaccharide (LPS)-unfolded protein response (UPR)- calcium overload-gene splicing”) açısından risk oluşturmaktadır. LUCOGS mekanizması ve sepsisle ilişkili süreci başlatmak üzere birbirleriyle etkileşimi tam olarak açığa kavuşmamıştır. Bu in vivo çalışma, hepatik uçbirleştirme ve UPR arasındaki ilişkinin aydınlatılmasını amaçlamaktadır. Yöntemler: Aydınlatılmış onam sonrasında hastaların yanık yaralarından Pseudomonas aeruginosa izolasyonu gerçekleştirilmiş ve LPS elde edilmiştir (hLPS). Erkek c57/BL6 fareler 6 gruba ayrılmıştır: 1. negatif kontrol (steril, apirojen normal salin) 2. pozitif kontrol (Tunikamisin) , 3. hLPS (3 mg/kg/intraperitoneal), 4. hLPS+ Dantrolen sodyum (kalsiyum kanal blokeri, CCI1) (A), 5. hLPS+2-aminometil fenil borinat (1 mg/kg) (CCI2) (B) ve 6. hLPS+CCI1/CCI2 (C). Uygulamalardan 2, 8 ve 24 saat sonra farelerin karaciğerleri adaptif UPR aktivasyonunun göstergesi olan XBP-1 birleştirmesinin değerlendirilmesi için çıkarılmıştır. Bulgular: hLPS grubuna kıyasla kombine hLPS ve CCl gruplarında XBP-1 birleştirme sayısı anlamlı olarak artış göstermiştir. Kontrollere kıyasla en yüksek XBP-1 birleştirme sayısı, Grup C’de 8 ve 24 saat sonra görülmüştür. Sonuçlar: Elde ettiğimiz veriler, CCl ile kombinasyonun, UPR gen uçbirleştirmesi modifikasyonu aracılığıyla hLPS ile indüklenmiş proinflamatuar aktivasyonu engelleyebileceğini göstermektedir. İki tür CCl uygulaması yaklaşımı ile indüklenmiş endotoksemi sonrasında hücre içi kalsiyum aşırı yüklenmesinin engellenmesi mümkün olabilir. Ayrı ayrı uygulanmalarına kıyasla kalsiyum kanal blokerlerinin birlikte uygulanmaları, (pro) inflamatuar süreçleri inhibe etme etkinliğini artırdığından sistemik dolaşımda LUGOGS yükselmesinin durdurulması ve organ yetmezliğinin engellenmesi için yeni bir strateji olarak değerlendirilebilir. Öne sürülen bu etkileşim mekanizmasının in vivo olarak daha detaylı ortaya konması için yeni uygulamanın etkinliğinin başka çalışmalarla desteklenmesi gereklidir.